AbCellera is mobilizing its pandemic response platform based on its rapid antibody discovery technology to respond to the 2019-nCoV outbreak.
AbCellera Is Mobilizing a Response to the Novel Coronavirus Outbreak as Part of Its DARPA P3 Program
Posted in futurism